m-gpe
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2013 (NCT01881581)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- m-gpe
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01881581 | Phase 1 | Jun 1, 2013 | Capital Medical University, Centers for Disease Control and Prevention, China, Chinese Academy of Medical Sciences, Government of China |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Centers for Disease Control and Prevention, China | Government | 1 | 1 | 1 | 2013 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Government of China | Government | 1 | 0 | 1 | 2013 |
4 organizations
Page 1 / 1